Concorde Asset Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$236K Sell
11,229
-695
-6% -$15.4K 0.14% 119
2026
Q2
$262K Buy
11,924
+437
+4% +$8.61K 0.15% 117
2026
Q1
$204K Buy
11,487
+676
+6% +$12.8K 0.1% 192
2025
Q4
$205K Buy
+10,811
New +$204K 0.08% 224

Other funds holding HQH

Concorde Asset Management's HQH Position: Q3 2026 in Review

Concorde Asset Management reduced its abrdn Healthcare Investors (HQH) stake by 5.8% in Q3 2026, selling an estimated $15.4K and leaving 11,229 shares worth $236K. The position accounts for 0.14% of the portfolio, ranked #119.

Concorde Asset Management first reported a position in HQH in Q4 2025 and has held it in 4 quarters since. The position peaked at $262K in Q2 2026. 117 funds tracked by Wall St. Rank hold HQH as of Q3 2026.

  • Concorde Asset Management held 11,229 shares of abrdn Healthcare Investors worth $236K as of Q3 2026.
  • Concorde Asset Management sold 695 abrdn Healthcare Investors shares in Q3 2026, an estimated $15.4K.
  • abrdn Healthcare Investors made up 0.14% of Concorde Asset Management's portfolio in Q3 2026, its #119 holding.
  • Concorde Asset Management first reported a position in abrdn Healthcare Investors in Q4 2025 and has held it in 4 quarters since.
  • Concorde Asset Management's abrdn Healthcare Investors position peaked at $262K in Q2 2026.
  • 117 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2026.

Based on Concorde Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.